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The Anatomical
Basis of Pulmonary
Vein Reconnection After
Ablation for Atrial Fibrillation
Wounds That Never Felt a Scar?*
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Sanjiv M. Narayan, MB, MD‡
Chicago, Illinois; and San Diego, California
Atrial fibrillation (AF), the most common cardiac arrhythmia,
is a major cause of strokes, hospitalizations, and mortality in
the United States. The toll of AF is expected to worsen in
coming decades as the number of elderly Americans increases
(1). This harsh demographic reality has provided an impetus to
eek new strategies to prevent, control, and eliminate the
rrhythmia. About a decade ago, it was discovered that AF is
requently triggered by ectopy or bursts of tachycardia that
riginate in muscle bundles that extend from the atrium to the
ulmonary veins (PVs) (2) and that electrical pulmonary vein
solation (PVI) by transcatheter ablation can maintain sinus
hythm. The past decade has witnessed great enthusiasm for
VI. With current techniques, 50% to 60% of patients remain
n sinus rhythm 1 year after a single procedure (3), but the
emainder show early or late recurrence of AF (4).
See page 930
In almost all cases in which AF recurs after PVI, 1 or more
of the PVs is found to have re-established electrical connection
to the atria (5–9). Although the pathological basis of PV
reconnection is not known, it is suspected to be caused by gaps
in the line of ablations (10) or failure to produce completely
transmural lesions (11), both undetected at the initial proce-
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from tissue remodeling or via additional conduits such as the
ligament of Marshall (12). A better understanding of the
mechanism of electrical reconnection may allow modification
of current procedural techniques or development of new tools
to achieve more durable PVI.
In this issue of the Journal, Kowalski et al. (13) provide
unique human data on the histopathology of the PV–left
atrial junction after PVI. To test whether PV reconnection
is associated with failure to produce a transmural scar, the
investigators took a simple yet ingenious approach. They
studied patients who were undergoing a surgical Cox maze
III procedure for recurrent AF after an initially successful
PVI procedure. All patients (N 12) were reported to have
ad complete electrical isolation of all 4 PVs at the time of
he index procedure. Epicardial mapping revealed that 34 of
8 (71%) PVs had re-established electrical connection to the
tria. As in previous studies (5–9), most patients (10 of 12
83%]) had at least 1 reconnected PV. After atriotomy, the
uthors examined the endocardial surface for scars and
btained 22 full-thickness biopsy specimens of the atrium at
oints where the atriotomy line crossed previous ablation
esions. Thus, although sampling was limited to the pre-
cribed surgical incisions, biopsy specimens that were taken
assed through visually confirmed prior ablation lesions.
iopsy specimens were classified as showing a transmural
car, a partial-thickness scar with viable myocardium, or
ntirely viable myocardium.
The authors’ results are summarized in Table 1. Biopsy
esults from PVs that maintained electrical isolation were
ore likely to show transmural scar (5 of 7 [71%]) than PVs
hat had reconnected (6 of 15 [40%]; p  0.36, Fisher exact
test). The results fall short of statistical significance, prob-
ably because of the small number of samples. Of note,
although one may expect that reconnected veins would show
gaps in the ablation line, actual biopsies showed an equal
distribution of histological types. Interestingly, biopsy re-
sults from reconnected veins showed an even distribution
across histological types even though one may expect a
preponderance of biopsy specimens showing gaps in the
ablation line. In these cases, gaps sufficient for PV recon-
nection may have been missed because it was not technically
feasible to take biopsy specimens along the entire circum-
ference of the PV. The authors concluded that electrical PV
reconnection was frequently seen in patients with recurrent AF
after initially successful PVI, and that the return of PV
conduction was associated with histopathologic evidence of
nontransmural lesions along the ablation line.
The authors should be commended for obtaining unique
human atrial biopsy data after transcatheter PVI and corre-
lating them with the presence or absence of electrical PV
connection. The results of this pilot series are consistent
with the hypothesis that PV reconnection is caused by an
anatomic gap in the ablation line or by failure to produce a
transmural scar. Just as importantly, the findings raise
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Pathology of PV Reconnection March 6, 2012:939–41several intriguing questions. Two PVs in the series showed
complete electrical isolation even though corresponding
biopsy results contained viable (i.e., nontransmurally
scarred) myocardium. This counterintuitive finding may be
explained by conduction block from scar proximal to the
biopsy site or potentially from source-sink effects. Further-
more, previous work from the authors’ laboratory has shown
that tissue geometry may enable conduction block despite
discontinuous ablation lines (14). A recent computer mod-
eling study revealed that the size of the maximum permis-
sible interlesion gap varies with tissue conductivity (10),
such that in a canine model with reduced conductivity (e.g.,
from ablation-related heating or inflammation), conduction
was blocked despite 3- to 5-mm gaps in ablation lines.
Thus, despite acute PVI at the index procedure in the series
by Kowalski et al. (13), PVs could theoretically have
reconnected with recovery of inflamed tissue without pos-
tulating healing of ablation lesions. Conductivity could also
recover with reversal of electrical remodeling from reduced
AF burden (15,16).
Recovery of PV conduction over longer time periods may
have a different mechanism. The median time to AF
recurrence in this study was 3.5 months (range 1 to 20
months), and others have reported recurrence as late as 5
years after ablation (17). Surprisingly, Kowalski et al. (13)
also report that tissue within PVI scar exhibited nuclear
pyknosis and myocytolysis months and even years after the
index ablation, suggesting that tissue can remain viable and
capable of recovery over a prolonged period of time. Late
reconnection may also occur through tissue remodeling or
through conduction across PV-atrial conduits (e.g., the
ligament of Marshall) that were undetected or nonfunc-
tional at the time of ablation (12).
Finally, durable PVI is not invariably associated with the
absence of AF. As stated in the present study (13), 2
patients had recurrent AF despite electrical isolation of all 4
PVs. It is possible that recurrent AF in these patients was
triggered and maintained by tissue outside the PVs (8,9).
Extra-PV mechanisms are more likely to cause persistent
AF than paroxysmal AF, and future studies should relate
recurrence to PV reconnection in patients with both types of
AF. Interestingly, it has been shown that PVs may recon-
nect even in patients without recurrent AF (18). Whether
this finding reflects insensitivity of clinical detection for AF,
reconnection of only “nonculprit” PVs, or other mechanisms
Summary of Study ResultsTable 1 Summary of Study Results
Finding
Transmural
Scar
Partial
Scar
Viable
Myocardium
Nonconducting PV 5 1 1
Conducting PV 6 6 3
Numbers of specimens in each category shown.
PV  pulmonary vein.remains uncertain.How should these results affect clinical practice? Clearly,
PVI is more likely to be successful if lesions are transmural
and contiguous. However, better indicators of transmural
damage are required than acute loss of conduction. Admin-
istration of adenosine or adenosine triphosphate (with or
without isoproterenol) may unmask dormant PV conduc-
tion (19–21), although the relevance of this finding has
recently been questioned (22). PV conduction may also be
transiently unmasked after cardioversion (23). Late gado-
linium enhancement on magnetic resonance imaging im-
mediately after ablation can identify nonenhancing lesions
that may form scar (11) and distinguish scar from pathol-
ogies such as edema (24). Such imaging may enable im-
proved techniques to ensure more durable PVI.
In summary, Kowalski et al. (13) should be commended
for an elegant and highly relevant clinical study. They have
provided objective pathological evidence in humans sup-
porting the hypothesis that PV reconnection is caused by a
failure to form a permanent uninterrupted surrounding
electrical barrier despite acute evidence for isolation. They
also show, counterintuitively, that PVs may remain electri-
cally isolated despite clear gaps in ablation lesions and
provide tissue data that may refine our concepts on ablation
lesion recovery. Future studies should extend this work to
test whether improvements in imaging, PVI, or other
techniques will provide more robust success from AF
ablation.
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